The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of enoblituzumab in combination with pembrolizumab in patients with advanced B7-H3-expressing cancers.
 
Naiyer A. Rizvi
Leadership - AstraZeneca
Stock and Other Ownership Interests - Gritstone Bio
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - Bristol-Myers Squibb (Inst)
 
Deryk Loo
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
Patents, Royalties, Other Intellectual Property - Author on patents submitted and published as an employee of MacroGenics, Inc. (Inst)
 
Jan E. Baughman
Employment - Macrogenics
Stock and Other Ownership Interests - MacroGenics
 
Soyoung Yun
Employment - MacroGenics
Stock and Other Ownership Interests - MacroGenics
 
Francine Chen
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
Patents, Royalties, Other Intellectual Property - Patent Award/Application: 1. Antibodies Reactive with B7H3 immunological activity fragments thereof and Uses Thereof 2. Bi-Specific Monovalent Diabodies That Are Capable Of Binding to GPA33 And CD3, And Uses Thereof (Inst)
 
Paul A. Moore
Stock and Other Ownership Interests - GlaxoSmithKline; Medtronic; Teva
Patents, Royalties, Other Intellectual Property - Have patents based on work at MacroGenics, Human Genome Sciences and Celera
 
Ezio Bonvini
Employment - MacroGenics
Leadership - MacroGenics
Stock and Other Ownership Interests - Macrogenics
Research Funding - MacroGenics (Inst)
Patents, Royalties, Other Intellectual Property - Patent application and issued patents held by the US Federal Government (I); Patent applications and issued patents held by MGNX
 
James Robert Vasselli
Employment - Macrogenics; MedImmune
Leadership - Macrogenics; MedImmune
Stock and Other Ownership Interests - Macrogenics; MedImmune
Honoraria - Macrogenics; MedImmune
Research Funding - Macrogenics; MedImmune
Travel, Accommodations, Expenses - Macrogenics; MedImmune
 
Jon M. Wigginton
Employment - Macrogenics
Leadership - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Roger B. Cohen
Consulting or Advisory Role - Cerulean Pharma; GlaxoSmithKline; Heat Biologics; Kolltan Pharmaceuticals; Takeda
Research Funding - Heat Biologics (Inst)
Travel, Accommodations, Expenses - Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Takeda
 
Charu Aggarwal
Consulting or Advisory Role - Celgene (I); Genentech; Genentech (I)
Speakers' Bureau - Genentech (I); Novartis (I); Pfizer (I)
Research Funding - Genentech/Roche; Millennium; Nektar
 
Anthony W. Tolcher
Employment - START
Leadership - Symphony Evolution
Consulting or Advisory Role - Akebia Therapeutics; ArQule; Asana Biosciences; Astex Pharmaceuticals; Bayer Schering Pharma; Bind Therapeutics; Blend Therapeutics; Celator; Dicerna; Endocyte; Genmab; Heron; Heron; Janssen; Johnson & Johnson; Johnson & Johnson; Mersana; Merus; Nanobiotix; Pharmacyclics; Pierre Fabre; Proximagen; Symphony Evolution; Upsher-Smith; Valent Technologies